Identification of screening tests for the detection of head and neck cancer at an early stage is an important strategy to improving prognosis. Our objective was to identify plasma circulating microRNAs for the diagnosis of head and neck cancer (oral and laryngeal subsites), within a multicenter International Head and Neck Cancer Epidemiology (INHANCE) consortium.

Pastorino, R., Sassano, M., Tiziano, D. F., Giraldi, L., Amore, R., Arzani, D., Abiusi, E., Ahrens, W., Alemany Vilches, L., Canova, C., Healy, C. M., Holcatova, I., Lagiou, P., Polesel, J., Popovic, M., Nygård, S., Cadoni, G., Znaor, A., Boffetta, P., Matsuo, K., Oze, I., Brennan, P., Boccia, S., Plasma miR-151-3p as a candidate diagnostic biomarker for head and neck cancer: a cross-sectional study within the INHANCE consortium, <<CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION>>, 2022; 2022 (13): 1-7. [doi:10.1158/1055-9965.EPI-22-0376] [http://hdl.handle.net/10807/217207]

Plasma miR-151-3p as a candidate diagnostic biomarker for head and neck cancer: a cross-sectional study within the INHANCE consortium

Pastorino, Roberta;Sassano, Michele;Tiziano, Danilo Francesco;Giraldi, Luca;Abiusi, Emanuela;Lagiou, Pagona;Cadoni, Gabriella;Boffetta, Paolo;Boccia, Stefania
2022

Abstract

Identification of screening tests for the detection of head and neck cancer at an early stage is an important strategy to improving prognosis. Our objective was to identify plasma circulating microRNAs for the diagnosis of head and neck cancer (oral and laryngeal subsites), within a multicenter International Head and Neck Cancer Epidemiology (INHANCE) consortium.
Inglese
Pastorino, R., Sassano, M., Tiziano, D. F., Giraldi, L., Amore, R., Arzani, D., Abiusi, E., Ahrens, W., Alemany Vilches, L., Canova, C., Healy, C. M., Holcatova, I., Lagiou, P., Polesel, J., Popovic, M., Nygård, S., Cadoni, G., Znaor, A., Boffetta, P., Matsuo, K., Oze, I., Brennan, P., Boccia, S., Plasma miR-151-3p as a candidate diagnostic biomarker for head and neck cancer: a cross-sectional study within the INHANCE consortium, <<CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION>>, 2022; 2022 (13): 1-7. [doi:10.1158/1055-9965.EPI-22-0376] [http://hdl.handle.net/10807/217207]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/217207
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact